Recurrent Uterine Corpus Cancer
4 clinical trials · Condition
◉ Watch Recurrent Uterine Corpus Cancer
| Record | Firm | Date |
|---|---|---|
| Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer (NCT02728258) | NRG Oncology | 2016-09-16 |
| Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer (NCT02059265) | National Cancer Institute (NCI) | 2014-02-14 |
| Trametinib With or Without GSK2141795 in Treating Patients With Recurrent or Persistent Endometrial Cancer (NCT01935973) | National Cancer Institute (NCI) | 2013-09-30 |
| Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer (NCT00492778) | GOG Foundation | 2008-02-25 |
Track Recurrent Uterine Corpus Cancer automatically
Every clearance here is in the API, with alerts when new ones post.